hypolipidemic drugs Flashcards

(40 cards)

1
Q

LDL

A

low density lipoproteins

  • transports cholesterol from liver to the blood stream
  • aka “bad cholesterol”
  • high levels in the blood are associated with an increased risk of atherosclerosis and coronary artery disease
  • normal 100 start treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HDL

A

High density lipoprotein
- “good cholesterol”
- HDLs acquire cholesterol from peripheral tissue i.e. arterial walls
- low HDL levels = risk factor for cardiovascular disease
-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

LP(a) Lipoprotein

A

formed from a LDL-like moiety and LP(a) protein

  • highly homologous to plasminogen but lacks the ability to be activated by tPA
  • repair of vessels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

competitive inhibition

A

has same Vmax different Km

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

noncompetitive inhibition

A

has same Km different Vmax (squashed graph)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cholesterol metabolism

A

?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

statins

A
simvastatin
fluvastatin
atorvastatin
pravastatin
lovastatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

statins use and MOA

A
  • lower LDL levels (by almost 60% ; TG down 40%)
    MOA: competitive inhibitors of HMC-CoA reductase
  • leads to an induction of high affinity LDL receptors–> thus lowering serum LDL levels
  • increasing LDL receptors is the important part of the mechanism!!

clinically all statins have the same efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

statin side effects

A
  1. elevations of serum aminotransferase and hepatotoxicity (increase in liver enzymes ALT/AST)
  2. myositis (muscle pain), marked by elevated creatine kinase activity
    - if drug is not discontinued, rhabdomyolysis may occur–> producing myoglobinemia –> may lead to acute renal failure

*always monitor liver enzymes and creatine kinase when giving statins!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

statin drug interactions

A
  • drugs that may inhibit CYP enzymes (erythromycin, ketoconazole) will increase the plasma concentrations of statins
  • concomitant use of amiodarone (class 3) or verapamil (class 4) or fibrates causes an increased risk of myopathy
  • statin + BABR/ezetimibe (which works better in conjunction with statins)
  • never use statins + fibrate bc toxicity! (myositis)
  • never combine statins + niacin bc toxicity! (myositis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

niacin

A

aka nicotinic acid

when used in high doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Niacin MOA and use

A
  • water soluble VB3 which is converted in the body into nicotinamide adenine dinucleotide (NAD) but in high [ ]
  • decreases plasma LDL levels and VLDL **
  • markledly decreases plasma TG levels
    mechanism primarily involves the inhibition of VLDL synthesis and esterification of Fatty Acids in the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Niacin Side Effects

A
  • flushing (PGE2–> vasodilation–> flushing…..treated by aspirin or other NSAIDS)
  • diarrhea
  • hyperuricemia (can precipitate gout)
  • hyperglycemia (so statins are preferred in diabetics)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fabric Acid Derivatives and use

A

Gemfibrozil
Fenofibrate

Use: Increases the activity of LPL and Reduces VLDL levels, especially TG!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fenofibrate MOA and use and A/E and drug interactions

A

MOA: agonist at peroxisome proliferator-activated receptor alpha (PPARalpha) which is a nuclear receptor

  • PPARalpha affects genes necessary for carb and fat metabolism –> activation –> increase plasma HDL and decrease plasma TG
  • increases the activity of lipoprotein lipase!!
  • reduces VLDL levels esp lowers triglycerides

Use: typically used to treat hypertriglyceridemias
(preferred over statins)

A/E:

  • GI symptoms
  • myopathy (increased with given with statins)
  • risk of cholesterol gallstones

Major Drug Interactions:
- fabric acid derivatives can displace other albumin bound drugs like warfarin–> thereby increase the anticoagulant effect of warfarin and sulfonyl ureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bile Acid Binding Resins and use

A

Colestipol
Cholestyramine
Colesevelam

Use: DECREASE LDL levels and INCREASE HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

drugs that may inhibit CYP enzymes

A
erythromycin (macrolide antibiotics)
ketoconazole
cimetidine
SSRIs
fluoroquinolones
HIV protease inhibitors
grapefruit juice
18
Q

CYP450 enzyme INDUCERS

A
rifampicin
barbiturates
phenytoin
carbamazepine
glucocorticoids
chronic alcohol administration
19
Q

Gemfibrozil MOA and use and A/E and drug interactions

A

MOA: agonist at peroxisome proliferator-activated receptor alpha (PPARalpha) which is a nuclear receptor

  • PPARalpha affects genes necessary for carb and fat metabolism –> activation –> increase plasma HDL and decrease plasma TG
  • increases the activity of lipoprotein lipase!!
  • reduces VLDL levels esp lowers triglycerides

Use: typically used to treat hypertriglyceridemias
(preferred over statins)

A/E:

  • GI symptoms
  • myopathy (increased with given with statins)
  • risk of cholesterol gallstones

Major Drug Interactions:
- fabric acid derivatives can displace other albumin bound drugs like warfarin–> thereby increase the anticoagulant effect of warfarin and sulfonyl ureas

20
Q

Colestipol: use, MOA, A/E and drug interactions

A

**Decreases LDL levels and increases HDL

MOA:

  • bind bile acids in the intestine forming a complex that is excreted in the feces
  • this leads to an increased oxidation of cholesterol to bile acids in the liver
  • this results in an increase in the number of low-density lipoprotein receptors –> thereby decreasing serum LDL levels

Side Effects:

  • constipation
  • bad taste (may lead to compliance issues)
  • deficiency of fat-soluble vitamins (as these resins bind bile acids they may interfere with normal fit digestion and absorption and thus may prevent absorption of fat soluble vitamin such as A, D, E and K)
  • side effects can even be seen at therapeutic doses compared to toxicities which are seen at higher than therapeutic doses*

Drug Interactions:
- may delay or reduce the absorption of other concomitant oral medications i.e. digitalis, warfarin

21
Q

Side Effects vs Toxicities

A
  • side effects can even be seen at therapeutic doses compared to toxicities which are seen at higher than therapeutic doses*
22
Q

patient has flushing. what drug did you give the patient and how do you treat it

A

the patient was given Niacin to lower LDL and VLDL

you treat this with aspirin or other NSAIDs

23
Q

cholestyramine: use, MOA, A/E and drug interactions

A

**Decreases LDL levels and increases HDL

MOA:

  • bind bile acids in the intestine forming a complex that is excreted in the feces
  • this leads to an increased oxidation of cholesterol to bile acids in the liver
  • this results in an increase in the number of low-density lipoprotein receptors –> thereby decreasing serum LDL levels

Side Effects:

  • constipation
  • bad taste (may lead to compliance issues)
  • deficiency of fat-soluble vitamins (as these resins bind bile acids they may interfere with normal fit digestion and absorption and thus may prevent absorption of fat soluble vitamin such as A, D, E and K)
  • side effects can even be seen at therapeutic doses compared to toxicities which are seen at higher than therapeutic doses*

Drug Interactions:
- may delay or reduce the absorption of other concomitant oral medications i.e. digitalis, warfarin

24
Q

Ezetimibe: use & toxicity

A

(zetia*)

  • Prodrug
  • lowers serum LDL and TG*
  • decreases GI absorption of cholesterol
  • used alone reduces LDL by 18% but MUCH more effective when given with statins (72%)

Toxicity: well-tolerated, MC side effect = diarrhea, abdominal pain

25
MOA = decrease synthesis of VLDL name that drug!
Niacin
26
MOA = decrease cholesterol synthesis and increase LDL receptors name that drug!
statins
27
MOA = interrupts enterohepatic circulation of bile acids and increases synthesis of bile acids and LDL receptors name that drug!
Bile acid binding resins Colestipol Cholestyramine colesevelam
28
colesevelam: use, MOA, A/E and drug interactions
**Decreases LDL levels and increases HDL MOA: - bind bile acids in the intestine forming a complex that is excreted in the feces - this leads to an increased oxidation of cholesterol to bile acids in the liver - this results in an increase in the number of low-density lipoprotein receptors --> thereby decreasing serum LDL levels Side Effects: - constipation - bad taste (may lead to compliance issues) - deficiency of fat-soluble vitamins (as these resins bind bile acids they may interfere with normal fit digestion and absorption and thus may prevent absorption of fat soluble vitamin such as A, D, E and K) * side effects can even be seen at therapeutic doses compared to toxicities which are seen at higher than therapeutic doses* Drug Interactions: - may delay or reduce the absorption of other concomitant oral medications i.e. digitalis, warfarin
29
MOA = increase LPL and TG hydrolysis name that drug!
Fibrates gemfibrozil fenofibrate
30
MOA = decrease intestinal absorption of cholesterol name that drug!
Ezetimibe
31
drug causes flushing, diarrhea, hepatic dysfunction, nausea, pruritus and gout name that drug!
niacin
32
drug causes hepatotoxicity and myopathy name that drug!
statins
33
drug causes hepatotoxicity, nausea and myositis name that drug!
Fibrates gemfibrozil fenofibrate
34
drug causes GI disturbances name that drug!
exetimibe
35
drug causes constipation, bloating, nausea and fat soluble vitamin deficiency name that drug!
Bile acid binding resins Colestipol Cholestyramine colesevelam
36
during drug treatment with atorvastatin it is important to routinely monitor serum concentrations of
alanine and aspartate transaminases and creatine kinase
37
two primary adverse effects HMG CoA inhibitors
hepatotoxicity and myopathy
38
dyslipidemia
general term associated with high cholesterol and/or high triglyceride (TG) levels in plasma.
39
CYP450 enzyme inducers
- rifampicin - barbiturates - phenytoin - carbamazepine - glucocorticoids - chronic alcohol use
40
CYP450 enzyme inhibitors
- cimetidine - SSRIs - ketoconazole - macrolide antibiotics - fluoroquinolones - HIV protease inhibitors - grapefruitjuice